Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNotes PayablesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Dna X (SONM) Treasury Shares (2018 - 2025)

Historic Treasury Shares for Dna X (SONM) over the last 8 years, with Q1 2025 value amounting to $621658.0.

  • Dna X's Treasury Shares fell 832.69% to $621658.0 in Q1 2025 from the same period last year, while for Mar 2025 it was $621658.0, marking a year-over-year decrease of 832.69%. This contributed to the annual value of $3769.0 for FY2024, which is 9447.24% down from last year.
  • Latest data reveals that Dna X reported Treasury Shares of $621658.0 as of Q1 2025, which was down 832.69% from $3769.0 recorded in Q4 2024.
  • Dna X's 5-year Treasury Shares high stood at $2.7 million for Q1 2021, and its period low was $3769.0 during Q4 2024.
  • For the 5-year period, Dna X's Treasury Shares averaged around $648878.7, with its median value being $347108.0 (2021).
  • As far as peak fluctuations go, Dna X's Treasury Shares skyrocketed by 108824.5% in 2021, and later plummeted by 9447.24% in 2024.
  • Over the past 5 years, Dna X's Treasury Shares (Quarter) stood at $347108.0 in 2021, then skyrocketed by 148.02% to $860888.0 in 2022, then crashed by 92.08% to $68185.0 in 2023, then plummeted by 94.47% to $3769.0 in 2024, then surged by 16393.98% to $621658.0 in 2025.
  • Its Treasury Shares was $621658.0 in Q1 2025, compared to $3769.0 in Q4 2024 and $51724.0 in Q3 2024.